Literature DB >> 29669197

Complications of Total Hip Arthroplasty in Patients With Ankylosing Spondylitis.

Michael M Ward1.   

Abstract

OBJECTIVE: To compare the risks of complications of primary total hip arthroplasty (THA) between patients with ankylosing spondylitis (AS) and those without AS.
METHODS: In this population-based study, we examined data from 1999 to 2013 of US Medicare beneficiaries (ages <75 years old) with AS and a comparison group without AS who had undergone primary THA. Complications were based on the Centers for Medicare & Medicaid Services 2013 THA Complication Measure, which included myocardial infarction, pneumonia, or sepsis within 7 days; surgical site bleeding, pulmonary embolus, or venous thrombosis within 30 days; or mechanical complications or local infection within 90 days. Mortality within 90 days, revision arthroplasty within 1 year, long length of stay, discharge to a care facility, and readmission within 90 days were also examined.
RESULTS: The study included 2,773 patients with AS and 107,341 patients without AS who had THA. Perioperative complications, 30-day complications, and local infections were rare in both groups (<1%). Mechanical complications and revision arthroplasty were uncommon in both groups. Ninety-day mortality was lower among patients with AS than those without AS (0.36% versus 0.7%). Patients with AS were more likely to be discharged to a care facility, and slightly more likely to have a long length of stay. Likelihood of a long stay was lower at hospitals that performed ≥100 THAs per year, but other complications were not associated with hospital volume.
CONCLUSION: Complications after primary THA are uncommon in patients with AS and similar in frequency to those without AS. Ninety-day mortality was lower among patients with AS. Published 2018. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Mesh:

Year:  2018        PMID: 29669197      PMCID: PMC6193863          DOI: 10.1002/acr.23582

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  34 in total

1.  Primary total hip arthroplasty in patients with ankylosing spondylitis.

Authors:  W M Tang; K Y Chiu
Journal:  J Arthroplasty       Date:  2000-01       Impact factor: 4.757

Review 2.  Total hip arthroplasty in ankylosing spondylitis: an analysis of 181 hips.

Authors:  Atul B Joshi; Ljubisa Markovic; Kevin Hardinge; John C M Murphy
Journal:  J Arthroplasty       Date:  2002-06       Impact factor: 4.757

3.  Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002.

Authors:  Steven Kurtz; Fionna Mowat; Kevin Ong; Nathan Chan; Edmund Lau; Michael Halpern
Journal:  J Bone Joint Surg Am       Date:  2005-07       Impact factor: 5.284

4.  Dynamic postural balance in ankylosing spondylitis patients.

Authors:  E Aydog; R Depedibi; A Bal; E Eksioglu; E Unlü; A Cakci
Journal:  Rheumatology (Oxford)       Date:  2005-11-08       Impact factor: 7.580

5.  Charnley total hip arthroplasty in ankylosing spondylitis: survivorship analysis of 76 patients followed for 8-28 years.

Authors:  M Y Lehtimäki; M U Lehto; H Kautiainen; K Lehtinen; M M Hämäläinen
Journal:  Acta Orthop Scand       Date:  2001-06

6.  Total hip arthroplasty in ankylosing spondylitis: outcome in 340 patients.

Authors:  S Sweeney; R Gupta; G Taylor; A Calin
Journal:  J Rheumatol       Date:  2001-08       Impact factor: 4.666

7.  Association of postoperative complications with hospital costs and length of stay in a tertiary care center.

Authors:  Nadia A Khan; Hude Quan; Jennifer M Bugar; Jane B Lemaire; Rollin Brant; William A Ghali
Journal:  J Gen Intern Med       Date:  2006-02       Impact factor: 5.128

8.  Hospital costs associated with surgical complications: a report from the private-sector National Surgical Quality Improvement Program.

Authors:  Justin B Dimick; Steven L Chen; Paul A Taheri; William G Henderson; Shukri F Khuri; Darrell A Campbell
Journal:  J Am Coll Surg       Date:  2004-10       Impact factor: 6.113

Review 9.  Orthopaedic procedure volume and patient outcomes: a systematic literature review.

Authors:  Nina Shervin; Harry E Rubash; Jeffrey N Katz
Journal:  Clin Orthop Relat Res       Date:  2007-04       Impact factor: 4.176

10.  Agreement between physicians' office records and Medicare Part B claims data.

Authors:  J B Fowles; A G Lawthers; J P Weiner; D W Garnick; D S Petrie; R H Palmer
Journal:  Health Care Financ Rev       Date:  1995
View more
  5 in total

Review 1.  Review article: Patient characteristics that act as risk factors for intraoperative complications in hip, knee, and shoulder arthroplasties.

Authors:  Adel Hijazi; Muhammad Talha Padela; Zain Sayeed; Aws Hammad; Kamela Devole; Todd Frush; Gamal Mostafa; Walid K Yassir; Khaled J Saleh
Journal:  J Orthop       Date:  2019-06-17

2.  NarxCare Scores Greater Than 300 Are Associated with Adverse Outcomes After Primary THA.

Authors:  Ahmed K Emara; Daniel Grits; Alison K Klika; Robert M Molloy; Viktor E Krebs; Wael K Barsoum; Carlos Higuera-Rueda; Nicolas S Piuzzi
Journal:  Clin Orthop Relat Res       Date:  2021-09-01       Impact factor: 4.755

3.  Robot-Assisted Total Hip Arthroplasty for Arthrodesed Hips.

Authors:  Wei Chai; Xiangpeng Kong; Minzhi Yang; Ken Lee Puah; Peifu Tang; Jiying Chen
Journal:  Ther Clin Risk Manag       Date:  2020-05-04       Impact factor: 2.423

4.  Total hip arthroplasty has higher complication rates in stiff spine patients: a systematic review and network meta-analysis.

Authors:  Sung Huang Laurent Tsai; Ngi Chiong Lau; Wei Cheng Chen; Ruei-Shyuan Chien; Eric H Tischler; Tsai-Sheng Fu; Dave Wei-Chih Chen
Journal:  J Orthop Surg Res       Date:  2022-07-16       Impact factor: 2.677

5.  Effects of types and degrees of ankylosing spondylitis hip structural damages on post-total hip arthroplasty outcome measurements.

Authors:  Siliang Man; Xiaojian Ji; Liang Zhang; Zhengyuan Hu; Yanwei Lv; Yixin Zhou; Hui Song; Feng Huang
Journal:  Medicine (Baltimore)       Date:  2020-11-13       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.